<DOC>
	<DOC>NCT00441922</DOC>
	<brief_summary>This trial will compare the efficacy of docetaxel versus vinorelbine as first-line treatment in elderly patients with advanced NSCLC.</brief_summary>
	<brief_title>Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)</brief_title>
	<detailed_description>Docetaxel and vinorelbine are well known active agents in the treatment of NSCLC. The standard treatment of elderly patients with advanced NSCLC is monotherapy with a third generation agent. The role of comprehensive geriatric assessment in treatment efficacy and tolerance is an area of investigation.</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Histologically or cytologically confirmed NonSmallCell Lung Cancer Stage IIIB/IV No prior chemotherapy Existence of twodimensional measurable disease. The measurable disease should not have been irradiated Life expectancy of more than 3 months Age ≥ 65 years Performance status (WHO) ≤ 3 Adequate bone marrow function (absolute neutrophil count &gt; 1000/mm^3, platelet count &gt; 100000/mm^3, Hemoglobin &gt; 9 gr/mm^3) Adequate liver (bilirubin &lt; 1.5 times upper limit of normal and SGOT/SGPT &lt; 2 times upper limit of normal), and renal function (creatinine &lt; 2 mg/dl) Informed consent Psychiatric illness or social situation that would preclude study compliance. Other concurrent uncontrolled illness Other invasive malignancy within the past 5 years except nonmelanoma skin cancer No absence or irradiated and stable central nervous system metastatic disease. No presence of a reliable care giver Other concurrent investigational agents</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Elderly</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Docetaxel</keyword>
	<keyword>Vinorelbine</keyword>
</DOC>